Women's Health x AI: Inside the Models Redefining Care
Join HBSANC and Doximity for a conversation with physicians, researchers, and builders working to improve how AI serves women’s health.
Collaborating alumni associations: Harvard Club of San Francisco, HBS Women's Association, HB Healthcare Alumni Association, Chicago Booth, Kellogg Executive Women's Network
As AI models are increasingly embedded in clinical decision-making and becoming the front door to healthcare for patients, how do we ensure that these tools adequately serve women and their health care needs?
AI is moving through healthcare at an unprecedented pace, with nearly a third of U.S. adults now using AI chatbots for health information (Rock Health) and two-thirds of physicians using AI daily or weekly in clinical care (Doximity 2026 Physician Compensation Report). In an under-researched and under-invested space like women's health, AI has tremendous potential for scientific discoveries and to democratize access to personalized information. However, AI models are largely trained on existing data, and women’s health has historically been under-researched and under-funded.
Date: Monday, October 26, 2026
Time: 5:30 - 7:30 pm PT
Venue: Doximity Office, JBar on the 5th Floor, 500 3rd Street, San Francisco, CA 94107
Agenda:
• 30 min Networking
• 60 min Panel (including Q&A)
• 30 min Networking and end
Tickets (Includes light snacks and drinks):
VIP Member: Free
HBSANC Member: $25
HCSF Member: $25
HBSHAA Member: $25
HBSWA, Kellogg Women's Network and Chicago Booth Member: $25
HBS Alumni but Non HBSANC Member: $35
Affiliated Clubs: $35
General Public: $45
Virtual Attendance: Livestream access via Zoom: $10.
Click Here To Register
**Zoom joining instructions will be emailed to registered livestream attendees before the event.
**Registration closes on Friday, October 23, at 12PM PT (or when sold out).
**Buy in advance online before attending. No tickets sold at the door. No cash or check payments to be accepted.
**All tickets are non-refundable and non-transferable
Speakers:
Nichole Young-Lin, MD, MBA
Dr. Nichole Young-Lin is an obstetrician-gynecologist and the Clinical Lead for Consumer Health GenAI and Women's Health at Google. At the forefront of digital health innovation, she shapes the product development, clinical research, and rigorous evaluation of generative AI experiences, including Google Health's personal health coaching and the Gemini app.
As a practicing safety-net OB/GYN, Dr. Young-Lin uniquely bridges frontline clinical reality with scalable AI technology. Her global health background includes advising the World Health Organization and co-founding an international maternal health nonprofit. Dr. Young-Lin holds an MD from UCSF, an MBA from Duke, and completed her residency at Stanford, where she continues to serve as adjunct faculty.
Jayaraman, MD
Dr. Tanvi Jayaraman is the Clinical Lead of Health AI at Oura, where she bridges medicine, artificial intelligence, and product strategy to advance responsible, trustworthy tools for everyday health. Her work ensures that Oura’s guidance—whether member- or clinician-facing—meets rigorous clinical standards while remaining intuitive and human-centered.
Before joining Oura, Dr. Jayaraman helped global diagnostics and pharmaceutical clients scale AI from pilots to production while at Bain & Company, and previously contributed to Apple's clinical team and helped shape early concepts for next-generation digital health tools. She has advised digital-health startups on clinical, regulatory, and genAI product strategy. At Stanford School of Medicine, she served as Women’s Clinic Lead at the Arbor Free Clinic and was one of two inaugural fellows in Stanford Health Care’s Healthcare Leadership & Administration fellowship, partnering with the Office of the CEO on system-level initiatives.
Her academic work spans clinician well-being and value-added medical education. She co-founded and staffed the Stanford Front Line COVID-19 Consult Service, an evidence synthesis program that rapidly answered clinicians’ questions during the pandemic. Earlier, as a U.S. Fulbright Scholar in Calabria, Italy, Dr. Jayaraman investigated barriers to care for survivors of intimate partner violence—work that informs her patient-first approach to technology and health equity.
Mitzi Krockover, MD
Mitzi Krockover, MD, is Director of Women's Health Innovation in Arizona State University's College of Health Solutions, where she builds initiatives connecting technology, innovation, and care delivery. She extends that work into the startup and investment world as Co-Founder of FemTechAZ and a Managing Director of Golden Seeds, where she co-chairs the Health Sector Group and helps lead the Arizona chapter.
An internist, Dr. Krockover has spent her career working to change how women's health is understood and delivered. She was the founding Medical Director of the Iris Cantor–UCLA Women's Health Center and later brought that perspective to the payer side as Vice President of Women's Health at Humana.
She serves on the board of the Black Women's Health Imperative and is active in the Milken Women's Health Network, Springboard Women's Health Council, and Women's Health Advocates. She also hosts and produces Beyond the Paper Gown, a podcast exploring the forces that shape women's health across the lifespan
Event Moderator:
Alice Zheng, MD, MBA, MPH
Alice Zheng, MD is currently VP, Clinical AI Partnerships at Doximity, driving clinical, strategic and commercial partnerships for a growing suite of AI tools for clinicians. She also advises startups, funds, non-profits and strategics in women's health.
She was previously a Partner at Foreground Capital, an early-stage healthcare VC fund, where she led multiple Seed/Series A investments in AI-enabled digital health and life science companies in women’s health and served on several boards. Prior to that, she was a McKinsey consultant in healthcare and trained clinically in internal medicine.
Alice holds an MD and MPH from the University of Michigan and an MBA from Harvard Business School. She is highly active in the clinical AI, digital health and women’s health ecosystems and also serves as an investment advisory board member at the Michigan Biomedical Venture Fund.